Low Vitamin D Symptoms: When to See a Doctor

What Low Vitamin D Symptoms Actually Feel Like

Vitamin D deficiency rarely announces itself with one dramatic symptom. It tends to produce a cluster of vague complaints that people often attribute to aging, stress, or poor sleep: fatigue that does not improve with rest, aching bones (especially in the lower back, hips, and legs), muscle weakness that makes it harder to climb stairs or rise from a chair, and a low mood that can resemble mild depression.

Muscle symptoms deserve attention because there is a plausible biological mechanism behind them. Vitamin D receptors are expressed in skeletal muscle, and deficiency impairs calcium handling within muscle fibers. Research on vitamin D supplementation and muscle strength, including a meta-analysis of randomized trials on muscle strength outcomes, has found modest but measurable improvements in grip and lower-extremity strength among people with low baseline levels, an effect that appears most relevant for older adults at risk of falls muscle strength meta-analysis. An editor should confirm the exact journal and effect size before this figure is published, since the source material available for this draft did not allow full verification of that detail.

Some research on vitamin D supplementation and acute respiratory infections has suggested an overall modest reduction in infection risk, with the clearest benefit in people who started out with very low vitamin D levels, though this remains an area of ongoing study.

Because fatigue, low mood, and muscle aches overlap heavily with thyroid disease, iron-deficiency anemia, and depression, a blood test rather than symptoms alone is what actually confirms or rules out vitamin D deficiency.

Why You Might Be Deficient

The body makes vitamin D3 (cholecalciferol) when UVB radiation strikes 7-dehydrocholesterol in the skin. Anything that limits UVB exposure or interferes with absorption and metabolism can lower levels.

Sunlight and geography. People living at higher latitudes make little to no vitamin D from sunlight during the winter months because the sun's angle filters out UVB wavelengths for part of the year Holick, vitamin D deficiency review. Consistent sunscreen use also substantially reduces cutaneous vitamin D synthesis.

Skin pigmentation. Melanin competes with 7-dehydrocholesterol for UVB photons, so deficiency is markedly more common in people with darker skin. Analyses of NHANES data have found large disparities in deficiency prevalence by race and ethnicity Forrest and Stuhldreher, NHANES vitamin D data.

Obesity. Vitamin D is fat-soluble, and adipose tissue sequesters circulating 25(OH)D, reducing how much is available in the bloodstream. Higher BMI is consistently associated with a higher risk of deficiency across pooled cohort data, according to observational research.

Malabsorption conditions. Celiac disease, Crohn's disease, chronic pancreatitis, and prior bariatric surgery all reduce intestinal absorption of fat-soluble vitamins. People who have had Roux-en-Y gastric bypass need lifelong monitoring and often need higher maintenance doses than someone without malabsorption; the exact adjustment varies by procedure and by how much absorption has changed, so dosing should be individualized with an endocrinologist or bariatric specialty team rather than estimated from a fixed multiplier, as clinical practice guidance generally recommends.

Medications. Glucocorticoids accelerate vitamin D breakdown. Anticonvulsants such as phenytoin and carbamazepine induce liver enzymes that inactivate 25(OH)D. Cholestyramine and orlistat impair fat absorption and, with it, vitamin D uptake.

Age. Skin's capacity to generate vitamin D from UVB declines with age, because the amount of 7-dehydrocholesterol in skin decreases over time as researchers have described in studies of aging skin.

Deciding When to Get Checked or Seek Care

Not everyone with mild fatigue or a dip in mood needs urgent evaluation, but a few scenarios change what you should do and how quickly.

The U.S. Preventive Services Task Force does not recommend universal vitamin D screening in asymptomatic adults, concluding that current evidence is insufficient to weigh the benefits and harms of population-wide screening USPSTF vitamin D deficiency screening recommendation. Targeted testing in people with symptoms or known risk factors remains standard practice.

Michael Holick, who led the panel that wrote the Endocrine Society's 2011 clinical practice guideline on vitamin D, has written that deficiency is common worldwide and should be considered in at-risk patients generally, not only in those who already show signs of bone disease Endocrine Society vitamin D guideline.

How Vitamin D Deficiency Is Diagnosed

The standard test is a serum 25-hydroxyvitamin D (25(OH)D) blood draw, which reflects total body stores from both diet and sun exposure. No fasting is required.

Interpreting results. The Endocrine Society's 2011 guideline defines deficiency as 25(OH)D below 20 ng/mL (50 nmol/L) and insufficiency as 21 to 29 ng/mL Endocrine Society vitamin D guideline. The Institute of Medicine uses a somewhat different framework, treating 20 ng/mL as adequate for bone health for most of the population Institute of Medicine dietary reference intakes. Many clinicians treating symptomatic patients aim for a level above 30 ng/mL, though the exact target should come from your own physician rather than a general guideline.

Depending on the clinical picture, a doctor may also order:

• Serum calcium and phosphorus, to check for hypocalcemia or secondary hyperparathyroidism.
• Intact parathyroid hormone (PTH), since an elevated PTH alongside low 25(OH)D points to secondary hyperparathyroidism, which can drive bone loss.
• Alkaline phosphatase, which can be elevated in osteomalacia.
• 24-hour urine calcium, if toxicity or a granulomatous disease is suspected.

A DEXA (bone density) scan may be appropriate for someone with confirmed deficiency and a fracture risk profile that warrants it. Correcting vitamin D deficiency before starting bisphosphonate therapy is standard clinical practice, since untreated deficiency can blunt the effectiveness of bone-building medications; this is a general practice point rather than a claim tied to a single study, and it should be confirmed with a treating physician.

Treatment: How Deficiency Is Corrected

The Endocrine Society's guideline outlines a general approach for adults with confirmed deficiency (25(OH)D below 20 ng/mL) that many clinicians follow, typically involving a higher weekly loading dose of cholecalciferol for six to eight weeks followed by a lower daily maintenance dose Endocrine Society vitamin D guideline. People with obesity or conditions that accelerate vitamin D breakdown often need higher doses in both phases. Exact numbers vary by patient, and dosing should always come from a clinician rather than self-directed high-dose supplementation.

Cholecalciferol (D3) is generally preferred over ergocalciferol (D2). A meta-analysis comparing the two forms found D3 more effective at raising and maintaining serum 25(OH)D levels Tripkovic et al., D2 versus D3 meta-analysis.

For people with malabsorption, intramuscular cholecalciferol or calcifediol (25-hydroxyvitamin D3) may be used instead of oral D3, because calcifediol bypasses one step of liver processing and can be better absorbed when the gut is compromised, based on clinical experience with malabsorptive conditions.

Monitoring. Levels are typically rechecked 8 to 12 weeks after starting treatment, with a goal in the 30 to 50 ng/mL range. Once that is reached, patients usually move to a maintenance dose with annual or semiannual rechecks.

The VITAL trial, a large randomized study led by JoAnn Manson, found that vitamin D supplementation did not reduce cardiovascular events or cancer incidence in a general population not selected for deficiency. That result supports targeting supplementation toward people with confirmed low levels rather than encouraging high-dose supplementation broadly VITAL trial, NEJM.

Vitamin D and Bone Health

Severe, prolonged deficiency causes osteomalacia in adults and rickets in children, both from inadequate mineralization of new bone matrix.

Osteomalacia produces diffuse bone pain, proximal muscle weakness, and sometimes a waddling gait. X-rays may show pseudofractures (Looser zones) at the medial femoral neck, pubic rami, or scapular borders. A bone biopsy is the definitive diagnostic method but is rarely needed when the clinical and lab picture is already clear.

A pooled analysis of randomized trials found that vitamin D supplementation at higher daily doses reduced hip fracture risk and, to a lesser extent, other non-vertebral fractures in adults over 65, while lower doses showed no clear benefit, according to a pooled analysis of randomized fracture-prevention trials. Calcium co-supplementation strengthened the effect in that analysis. These findings are part of why the Endocrine Society recommends that adults 50 and older at risk of falls or fractures maintain 25(OH)D levels above 30 ng/mL.

Vitamin D and Mood: What the Evidence Shows

Observational studies consistently link low 25(OH)D to higher rates of depression. A meta-analysis found meaningfully higher odds of depression among people in the lowest range of vitamin D compared with the highest Anglin et al., vitamin D and depression meta-analysis. Vitamin D receptors are present in brain regions involved in mood regulation, which offers a plausible biological mechanism, though observational links like this cannot prove that low vitamin D causes depression.

Trial evidence is more modest. A meta-analysis of randomized trials found a small but statistically significant improvement in depressive symptoms with vitamin D supplementation, with the clearest effect in people who started out deficient, according to a meta-analysis of randomized trials.

The practical takeaway is that correcting a real deficiency may help mood somewhat in people who are genuinely low, but vitamin D is not a substitute for established depression treatment such as therapy or medication in moderate to severe cases.

Special Populations at Higher Risk

Some groups are worth screening proactively rather than waiting for symptoms.

Pregnant women. Maternal vitamin D deficiency has been associated with preeclampsia, gestational diabetes, and small-for-gestational-age birth in observational studies. The American College of Obstetricians and Gynecologists recommends 600 IU daily during pregnancy, with higher doses considered when deficiency is confirmed by testing ACOG committee opinion on vitamin D in pregnancy.

Older adults in long-term care. People in nursing homes have very limited sun exposure, and deficiency is common in this population. Supplementation combined with calcium is standard practice for fall and fracture prevention in this group.

People on chronic glucocorticoids. Long-term steroid use accelerates vitamin D breakdown. Guideline-level recommendations call for vitamin D and calcium co-supplementation for anyone expected to be on glucocorticoids for three months or longer.

People after bariatric surgery. Lifelong monitoring, typically every 6 to 12 months, is recommended, with maintenance dosing titrated to keep 25(OH)D above 30 ng/mL rather than fixed to a single standard dose as is generally recommended in bariatric care.

Food Sources and Practical Supplementation Notes

Few foods naturally contain meaningful vitamin D. Wild-caught fatty fish such as salmon is one of the better sources; fortified milk and egg yolks contribute smaller amounts Holick, vitamin D deficiency review. Diet alone rarely corrects an established deficiency.

Taking vitamin D3 with a meal that contains some fat may modestly improve absorption, since it is a fat-soluble vitamin, though the exact size of that benefit varies across studies and should not be treated as a precise number.

Toxicity from supplementation is rare at standard doses. When it happens, the underlying problem is hypercalcemia rather than vitamin D itself, with symptoms such as nausea, excess urination, kidney stones, and confusion. The Institute of Medicine's more conservative tolerable upper intake for the general population is 4,000 IU per day; some guidelines allow higher supervised doses in confirmed deficiency. Anyone on thiazide diuretics should have calcium checked when starting vitamin D, because thiazides reduce how much calcium the kidneys excrete, which can raise the risk of hypercalcemia when combined with supplementation.

The Bottom Line

Ask your doctor about a 25(OH)D blood test if you have persistent fatigue, bone pain, muscle weakness, recurrent infections, or belong to a higher-risk group (BMI over 30, dark skin, limited sun exposure, a malabsorption condition, or age over 65). Seek care promptly, not routinely, for an unexplained fracture, severe muscle weakness, spasms or tingling around the mouth, or signs of rickets in a child. Confirmed deficiency generally responds well to supervised cholecalciferol treatment, with levels rechecked 8 to 12 weeks after starting therapy Endocrine Society vitamin D guideline. This article is educational and does not replace an individualized diagnosis or dosing plan from your own clinician.